HLB Cell is a regenerative medicine biotech company focusing on the R&D,
clinical development, manufacturing and sales of biodegradable/biocompatible medical devices,
stem cell therapeutics and advanced tissue engineering products.
We have been developing Hutrigel® platform technology, which is a technology to produce and apply a human cell culture-derived extracellular matrix.
We are expanding its application to research reagents, medical devices and aesthetic materials. Additionally, we are developing BleeFix®, a surgical hemostat with superior adhesion, gel strength and biocompatibility compared to commercial starch-based ones as well as LifeLiver®, a bioartificial liver that is a combination product of a cell therapeutic and a medical device to support liver function.
HLB Cell is dedicated to contributing human health by developing next-generation medical devices and regenerative medicinal products using innovative platform technologies that are able to overcome the limitations of previous tissue engineering and regenerative medicine.